{
    "2018-05-28": [
        [
            {
                "time": "2018-03-15",
                "original_text": "What Trends Will Drive Long-Term Growth for Opdivo and Eliquis?",
                "features": {
                    "keywords": [
                        "Opdivo",
                        "Eliquis",
                        "long-term growth",
                        "trends"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "How Analysts View Approval Delay of Tevaâ€™s Migraine Drug",
                "features": {
                    "keywords": [
                        "Teva",
                        "migraine drug",
                        "approval delay",
                        "analysts view"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}